Review of survival, safety, and clinical outcomes in HER2+ metastatic gastric cancer following the administration of trastuzumabPost-Trastuzumab Gastric Cancer-Reference-Cited by-同舟云学术

Review of survival, safety, and clinical outcomes in HER2+ metastatic gastric cancer following the administration of trastuzumabPost-Trastuzumab Gastric Cancer

Published:2020 Issue: Volume:24 Page:100189
ISSN:2468-2942
Container-title:Cancer Treatment and Research Communications
language:en
Short-container-title:Cancer Treatment and Research Communications

Author:

Hackshaw Michelle D.,Bui Christine L.,Ladner Amy,Tu Nora,Islam Zahidul,Ritchey Mary E.,Salas Maribel

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference45 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Bray;CA Cancer J. Clin.,2018

2. Clinical impact of intratumoral HER2 heterogeneity on trastuzumab efficacy in patients with HER2-positive gastric cancer;Wakatsuki;J. Gastroenterol.,2018

3. Personalized medicine in gastric cancer: where are we and where are we going?;Jacome;World J. Gastroenterol.,2016

4. Multicenter phase III comparison of cisplatin/S-1 with cisplatin/infusional fluorouracil in advanced gastric or gastroesophageal adenocarcinoma study: the FLAGS trial;Ajani;J. Clin. Oncol.,2010

5. Phase III study of docetaxel and cisplatin plus fluorouracil compared with cisplatin and fluorouracil as first-line therapy for advanced gastric cancer: a report of the V325 Study Group;Van Cutsem;J. Clin. Oncol.,2006

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tailoring second-line or above therapy for patients with advanced or metastatic gastric cancer: A multicenter real-world study;Frontiers in Pharmacology;2022-11-17

2. Patient and caregiver socioeconomic burden of first-line systemic therapy for advanced gastroesophageal adenocarcinoma;Future Oncology;2022-03

3. Chemotherapeutic Protocols for the Treatment of Gastrointestinal Tract Cancer;Chemotherapy Protocols and Infusion Sequence;2022